A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn which doses of PS433540 should be given to patients
with high blood pressure to lower their blood pressure. This study will also examine how safe
PS433540 is when taken by patients with high blood pressure. Approximately 720 patients will
be evaluated so that about 375 patients will be entered into the treatment phase of the study
and be given PS433540.